Baird Initiates Coverage of Caris Life Sciences, Inc. (CAI) with an Outperform Rating

Caris Life Sciences, Inc. (NASDAQ:CAI) is among the 11 Newly-Listed NASDAQ Stocks to Buy Now. Baird Initiates Coverage of Caris Life Sciences, Inc. (CAI) with an Outperform Rating On February 17, 2026, Baird initiated coverage of Caris Life Sciences, Inc. (NASDAQ:CAI) with an Outperform rating and a $26 price target. Baird described Caris Life Sciences, Inc. (NASDAQ:CAI) as a commercial-stage precision oncology company focused on comprehensive molecular information and machine learning algorithms. While ...